Ann C. Miller - 21 Mar 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Director
Signature: /s/ Ann C. Miller
Issuer symbol: INO
Transactions as of: 21 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Mar 2022, 16:15:18 UTC
Previous filing: 17 Jun 2021
Next filing: 17 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+4,273	+17%		29,534	21 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-4,273	-100%	$0.000000^*	0	21 Mar 2022	Common Stock	4,273		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on March 21, 2020; 4,274 shares vested on March 21, 2021; 4,273 shares vested on March 21, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.